Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Revenue (2016 - 2018)

ENDRA Life Sciences has reported Revenue over the past 3 years, most recently at $6174.0 for Q1 2018.

  • Quarterly Revenue changed N/A to $6174.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $6174.0 through Dec 2018, down 98.24% year-over-year, with the annual reading at $6174.0 for FY2018, 98.24% down from the prior year.
  • Revenue was $6174.0 for Q1 2018 at ENDRA Life Sciences, down from $6850.0 in the prior quarter.
  • Over five years, Revenue peaked at $515582.0 in Q4 2016 and troughed at $6174.0 in Q1 2018.
  • The 3-year median for Revenue is $57772.0 (2017), against an average of $174675.6.
  • The largest YoY upside for Revenue was 98.67% in 2017 against a maximum downside of 98.67% in 2017.
  • A 3-year view of Revenue shows it stood at $515582.0 in 2016, then plummeted by 98.67% to $6850.0 in 2017, then decreased by 9.87% to $6174.0 in 2018.
  • Per Business Quant, the three most recent readings for NDRA's Revenue are $6174.0 (Q1 2018), $6850.0 (Q4 2017), and $287000.0 (Q3 2017).